FDA Investigator Kathleen R Jones, PhD
Kathleen R Jones, PhD has inspections in 6 countries as of 13 Oct 2023. Kathleen R Jones, PhD has collaborated with a combinined 3521 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
13
Last Inspection Date:
13 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America,
Spain,
Ireland,
Germany,
Portugal,
Netherlands
Co-Investigator(s):
Aimee Cunningham, PhD,
Amalia C Himaya,
Amalia Himaya,
Amy Devlin, PhD,
Andrey Sarafanov, PhD,
Anh M Lac,
Anissa M Cheung,
Anita Narula, PhD,
Ann L Demarco,
Arie C Menachem,
Arulvathani P Arudchandran,
Azza Talaat,
Barbara Janine Breithaupt,
Barry Cherney, PhD,
Bazarragchaa Damdinsuren, PhD,
Bichsa T Nguyen,
Bichsa T Tran,
Bo Chi, PhD,
Brenda P King,
Brenda W Uratani, PhD,
Brentley S Collins,
Brently S Collins,
Brian D Nicholson,
Brien C Fox,
Burnell M Henry,
Carla J Lundi,
Caryn M Mcnab,
Chen Sun, PhD,
Cheron M Portee,
Christian D Lynch (CDL),
Christina Capacci Daniel, PhD,
Christina V Santos,
Christopher D Leach,
Christopher Downey, PhD,
Daniel W Cline,
David M Beltran,
Davinna Ligons, PhD,
Dawn M Braswell,
Diane Cvan Leeuwen,
Diane L Raccasi,
Doan T Nguyen, PharmD,
Donald C Obenhuber, PhD,
Donna Ltartaglino Besone,
Dr. Ralph M Bernstein, PhD,
Ekaterina Allen,
Eliezar Ramos,
Ellen Huang,
Ellen P Madigan,
Erika V Butler,
Felix Maldonado,
Frances Namuswe, PhD,
Frederick Razzaghi,
Gene D Arcy,
Gunther Bockhoudt,
Gunther Boekhoudt, PhD,
Haley H Seymour,
Haley Seymour,
Haroon Vohra (NMI),
Hasan A Irier, PhD,
Hector A Carrero,
Helen B Ricalde,
Iris C Macinnes,
James R Fleckenstein,
Jason F Chancey,
Jee Chung, PhD,
Jeffrey P Raimondi,
Jennifer Gogley,
Jennifer M Gogley,
Joel Welch, PhD,
John D White,
John R Myung,
Joyce A Rockwell,
Julie D Bringger,
Jun Park, PhD,
Justin A Boyd,
Justine M Corson,
Ka L Wong,
Kalavati Suvarna, PhD,
Kara A Scheibner, PhD,
Kellie L Thommes, RN,
Kelvin Cheung,
Kelvin X Sanders,
Kendra A Biddick,
Kevin A Gonzalez,
Kim Lthomas Cruse,
Kurt A Brorson, PhD,
Laura Fontan, MS,
Laurimer Kuilan Torres,
LCDR Debra Emerson,
Leonard H Lavi,
Lori P Peters,
Luis M Burgos Medero,
Marcia Britt Williams,
Marcus F Yambot,
Maria G Gutierrez Hoffman,
Maria Gutierrez Hoffman, PhD,
Maria Joselopez Barragan, PhD,
Mariza M Jafary,
Mark Brunswick, PhD,
Marlene G Swider,
Martha T Olone,
Mary E Storch,
Matthew B Casale,
Maxwell Van Tassell, PhD,
Maxyne T Lam,
Megan A Haggerty,
Meisha R Sampson,
Meisha Waters,
Merry Christie, PhD,
Michael Shanks, MS,
Michele L Forster, PhD,
Michelle A Marsh,
Michelle M Noe,
Michelle Y Clark Stuart,
Mihaly S Ligmond,
Milos Dokmanovic, PhD,
Miriam M Ngundi,
Mohsen Rajabi Abhari, FDA,
Monica Commerford, PhD,
Monique C Lo,
Mra Munizn,
Muna Algharibeh,
Nailing Zhang,
Nibin Varghese, MS,
Nicholas Obiri, PhD,
Nicola M Fenty Stewart,
Nicole C Victoria, PhD,
Obinna R Echeozo,
Omotunde O Osunsanmi,
Patrick J Lynch,
Paula A Trost,
Peter S Diak,
Prabhu P Raju,
Priscilla M Pastrana,
Qing Joanna Zhou, PhD,
Ramesh Potla, PhD,
Rebecca E Dombrowski,
Rebecca Rodriguez,
Reyes Candau Chacon, PhD,
Richard H Penta,
Richard Ledwidge (nmi), PhD,
Richard W Berning,
Richard W Thornton,
Richmond K Yip,
Riley C Myers, PhD,
Robert D Tollefsen,
Robert Darius,
Robert W Jennings,
Roger F Zabinski,
Ronald L Koller,
Ronda Lebland,
Rong Wang, PhD,
Rose M Ashley,
Russell J Glapion,
Sarah Arden,
Scott R Nichols, PhD,
Sean R Marcsisin,
Seth A Mailhot,
Sidney B Priesmeyer,
Sonia R Peterson,
Stacey S Degarmo,
Stanley Au,
Steven D Kehoe,
Steven Fong, MS, PhD,
Taichun Qin, PhD,
Terri L Dodds,
Thao T Kwan,
Thao Tran,
Thao X Tran,
Thuy T Nguyen, LCDR,
Tracy Denison, PhD,
Unnee Ranjan,
Uttaniti Limchumroon (Tom),
Vaishali J Patel,
Veronica Fuentes, MS,
Victor J Gangi,
Virgilio F Pacio, CSO,
Walter Lange,
Walter N Lange,
Wayne E Seifert,
Wendy G Tan, PhD,
Yanming An, PhD,
Yumi J Hiramine,
Yvonne C Wilkes,
Zerita White,
Zhihao Qiu (Peter), PhD,
Zhong Li, PhD,
Ziyang Su, PhD
Kathleen R Jones, PhD's Documents
| Publish Date | Document Type | Title |
|---|---|---|
| February, 2020 | FDA 483 | Novo Nordisk US Bio Production Inc. - Form 483, 2020-02-14 |
| February, 2018 | FDA 483 | Patheon Biologics B.V. - Form 483, 2018-02-13 |
| November, 2017 | FDA 483 | Kashiv BioSciences, LLC - Form 483, 2017-11-21 |
| July, 2021 | FDA 483 | Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC - Form 483, 2021-07-23 |
| May, 2017 | FDA 483 | BioMarin International Limited - Form 483, 2017-05-02 |
| November, 2017 | EIR | Kashiv BioSciences, LLC - EIR, 2017-11-21 |
Experience Redica System's NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more